Optimal timing and treatment strategy for pancreatic cancer.

Adriana C GamboaManali RupjiJeffrey M SwitchenkoRachel M LeeMichael K TurgeonBenjamin I MeyerMaria C Russell Kenneth Cardona David A KoobyShishir K MaithelRachel E NeMoyer

Published in: Journal of surgical oncology (2020)

For PDAC, initiation of therapy within 6 weeks from diagnosis is associated with improved survival, with neoadjuvant chemotherapy associated with the best survival compared with neoadjuvant chemoradiation or upfront surgery.

Keyphrases

neoadjuvant chemotherapy
locally advanced
rectal cancer
lymph node
squamous cell carcinoma
radiation therapy
sentinel lymph node
minimally invasive
free survival
coronary artery bypass
surgical site infection
atrial fibrillation
mesenchymal stem cells
coronary artery disease
smoking cessation
preterm birth